Want to see DCGO full AI Analyst Report?
DCGO Stock Chart & Stats
$0.38
-$0.07(-11.07%)
At close: 4:00 PM EDT
$0.38
-$0.07(-11.07%)
Day’s Range― - ―
52-Week Range$0.35 - $1.65
Previous CloseN/A
Volume791.43K
Average Volume (3M)864.94K
Market Cap
$40.05M
Enterprise Value$28.39
Total Cash (Recent Filing)$25.23M
Total Debt (Recent Filing)$25.91M
Price to Earnings (P/E)―
Beta1.59
Next Earnings
Nov 09, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.96
Shares Outstanding98,928,370
10 Day Avg. Volume988,209
30 Day Avg. Volume864,942
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.60
Price to Sales (P/S)0.27
P/FCF Ratio3.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$2.17Price Target Upside470.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)-0.35
Revenue Forecast (FY)$306.63M
Bulls Say, Bears Say
Bulls Say
Core Volume And Revenue GrowthUnderlying demand remains healthy despite the migrant-program wind-down. Growth across home healthcare, virtual care, transportation and phlebotomy supports a broader recurring care-delivery platform and reduces reliance on discontinued projects.
AI-Enabled Operating EfficiencyAutomation can improve scalability and labor productivity as service volumes grow. The existing call and data-entry deployments provide measurable proof points, while additional programs could support lower administrative costs and more durable margins.
Expanded Care-at-Home PlatformThe proposed combination would broaden DocGo’s clinical offering and create cross-selling opportunities with health systems and payers. A more integrated virtual and in-home platform could strengthen customer relevance and support larger enterprise contracts.
Bears Say
Severe Profitability DeteriorationLosses have replaced the modest profitability achieved in earlier periods, while management lowered near-term earnings expectations. Persistent operating losses indicate that revenue growth is not yet translating into sustainable profitability.
Cash Burn And Financing RiskNegative cash conversion reduces financial flexibility and may require external financing if losses continue. The planned Hicuity transaction adds approximately $52 million of assumed debt, increasing obligations while liquidity is already declining.
Margin And Reimbursement PressureLower mobile-health and consolidated margins show that labor and operating costs are constraining unit economics. Potential CMS reimbursement reductions could further weaken selected RPM revenue and make profitable growth harder to achieve.
DocGo News
DCGO FAQ
What was DocGo’s price range in the past 12 months?
DocGo lowest stock price was $0.35 and its highest was $1.65 in the past 12 months.
What is DocGo’s market cap?
DocGo’s market cap is $40.05M.
When is DocGo’s upcoming earnings report date?
DocGo’s upcoming earnings report date is Nov 09, 2026 which is in 65 days.
How were DocGo’s earnings last quarter?
DocGo released its earnings results on Aug 17, 2026. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.098 by -$0.062.
Is DocGo overvalued?
According to Wall Street analysts DocGo’s price is currently Undervalued.
Does DocGo pay dividends?
DocGo does not currently pay dividends.
What is DocGo’s EPS estimate?
DocGo’s EPS estimate is -0.11.
How many shares outstanding does DocGo have?
DocGo has 98,928,370 shares outstanding.
What happened to DocGo’s price movement after its last earnings report?
DocGo reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.098. Following the earnings report the stock price went down -33.099%.
Which hedge fund is a major shareholder of DocGo?
Currently, no hedge funds are holding shares in DCGO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DocGo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.17 (470.18% Upside)
$2.17 (470.18% Upside)
Blogger Sentiment
Bullish
DCGO Sentiment 67%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 4.3%
Last 30 Days ▼ 4.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-73.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-54.24%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
DocGo
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
DCGO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed strong operational momentum (record volumes across multiple business lines, solid organic growth after excluding one-time migrant revenues, a strategic acquisition with committed financing, and tangible AI-driven efficiency programs) alongside material near-term financial pressures (widened adjusted EBITDA loss guidance, ongoing negative adjusted EBITDA, declining cash balances, margin compression in mobile health, and the addition of assumed Hicuity debt). Management expects improvements (positive adjusted EBITDA run rate exiting 2026) but execution and timing risks remain.View all DCGO earnings summariesDCGO Stock 12 Month Forecast
Average Price Target
$2.17
▲(470.18% Upside)
Technical Analysis
Ownership Overview
6.98% Insiders
8.25% Mutual Funds
15.52% Other Institutional Investors
64.67% Public Companies and
Individual Investors